1. Bailly M, Venel Y, Orain I et al. (2016) 18F-FDG PET in Liver Transplantation Setting of Hepatocellular Carcinoma: Predicting Histology?Clin Nucl Med 41:e126-129
2. Bauschke A, Altendorf-Hofmann A, Ardelt M et al.(2020) Impact of successful local ablative bridging therapy prior to liver transplantation on long-term survival in patients with hepatocellular carcinoma in cirrhosis. J Cancer Res Clin Oncol 146:1819-1827
3. Bauschke A, Altendorf-Hofmann A, Kissler H et al. (2017) Validity of eleven prognostic scores with respect to intra- and extrahepatic recurrence of hepatocellular carcinoma after liver transplantation. J Cancer Res Clin Oncol 143:2595-2605
4. Brierley J, Gospodarowicz MK, Wittekind C (2017) TNM classification of malignant tumours. John Wiley & Sons, Inc., Chichester, West Sussex, UK ; Hoboken, NJ
5. Detry O, Govaerts L, Deroover A et al. (2015) Prognostic value of (18)F-FDG PET/CT in liver transplantation for hepatocarcinoma. World J Gastroenterol 21:3049-3054
6. Gordon-Weeks AN, Snaith A, Petrinic T et al. (2011) Systematic review of outcome of downstaging hepatocellular cancer before liver transplantation in patients outside the Milan criteria. The British journal of surgery 98:1201-1208
7. Halazun KJ, Hardy MA, Rana AA et al. (2009) Negative impact of neutrophil-lymphocyte ratio on outcome after liver transplantation for hepatocellular carcinoma.Ann Surg 250:141-151
8. Hsu CC, Chen CL, Wang CC et al.(2016) Combination of FDG-PET and UCSF Criteria for Predicting HCC Recurrence After Living Donor Liver Transplantation. Transplantation 100:1925-1932
9. Iwata Y, Shiomi S, Sasaki N et al. (2000) Clinical usefulness of positron emission tomography with fluorine-18-fluorodeoxyglucose in the diagnosis of liver tumors. Ann Nucl Med 14:121-126
10. Kang YK, Choi JY, Paeng JC et al. (2019) Composite criteria using clinical and FDG PET/CT factors for predicting recurrence of hepatocellular carcinoma after living donor liver transplantation. Eur Radiol 29:6009-6017
11. Kim YI, Paeng JC, Cheon GJ et al. (2016) Prediction of Posttransplantation Recurrence of Hepatocellular Carcinoma Using Metabolic and Volumetric Indices of 18F-FDG PET/CT.J Nucl Med 57:1045-1051
12. Kornberg A, Witt U, Schernhammer M et al.(2017) Combining (18)F-FDG positron emission tomography with Up-to-seven criteria for selecting suitable liver transplant patients with advanced hepatocellular carcinoma. Sci Rep 7:14176
13. Lee SD, Kim SH, Kim YK et al. (2013) (18)F-FDG-PET/CT predicts early tumor recurrence in living donor liver transplantation for hepatocellular carcinoma. Transpl Int 26:50-60
14. Lee SD, Lee B, Kim SH et al. (2016) Proposal of new expanded selection criteria using total tumor size and (18)F-fluorodeoxyglucose - positron emission tomography/computed tomography for living donor liver transplantation in patients with hepatocellular carcinoma: The National Cancer Center Korea criteria. World J Transplant 6:411-422
15. Llovet JM, Lencioni R, Di Bisceglie AM et al. (2012) EASL-EORTC Clinical Practice Guidelines: Management of hepatocellular carcinoma. Journal of Hepatology 56:908-943
16. Mazzaferro V, Regalia E, Doci R et al. (1996) Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. The New England journal of medicine 334:693-699
17. Millonig G, Graziadei IW, Freund MC et al. (2007) Response to preoperative chemoembolization correlates with outcome after liver transplantation in patients with hepatocellular carcinoma. Liver Transpl 13:272-279
18. Otto G, Herber S, Heise M et al. (2006) Response to transarterial chemoembolization as a biological selection criterion for liver transplantation in hepatocellular carcinoma. Liver Transpl 12:1260-1267
19. Pavel MC, Fuster J (2018) Expansion of the hepatocellular carcinoma Milan criteria in liver transplantation: Future directions. World J Gastroenterol 24:3626-3636
20. Peduzzi P, Concato J, Feinstein AR et al. (1995) Importance of events per independent variable in proportional hazards regression analysis. II. Accuracy and precision of regression estimates. J Clin Epidemiol 48:1503-1510
21. Ravaioli M, Grazi GL, Piscaglia F et al. (2008) Liver transplantation for hepatocellular carcinoma: results of down-staging in patients initially outside the Milan selection criteria. Am J Transplant 8:2547-2557
22. Roayaie S, Schwartz JD, Sung MW et al. (2004) Recurrence of hepatocellular carcinoma after liver transplant: patterns and prognosis. Liver Transpl 10:534-540
23. Seo S, Hatano E, Higashi T et al. (2007) Fluorine-18 fluorodeoxyglucose positron emission tomography predicts tumor differentiation, P-glycoprotein expression, and outcome after resection in hepatocellular carcinoma. Clin Cancer Res 13:427-433
24. Takada Y, Kaido T, Shirabe K et al. (2017) Significance of preoperative fluorodeoxyglucose-positron emission tomography in prediction of tumor recurrence after liver transplantation for hepatocellular carcinoma patients: a Japanese multicenter study. J Hepatobiliary Pancreat Sci 24:49-57
25. Winkens T, Rudakoff W, Rauchfuss F et al. (2021) FDG PET/CT to Detect Incidental Findings in Patients With Hepatocellular Carcinoma-Additional Benefit for Patients Considered for Liver Transplantation? Clin Nucl Med
26. Yang SH, Suh KS, Lee HW et al. (2006) The role of (18)F-FDG-PET imaging for the selection of liver transplantation candidates among hepatocellular carcinoma patients. Liver Transpl 12:1655-1660
27. Ye YF, Wang W, Wang T et al. (2017) Role of [(18)F] fludeoxyglucose positron emission tomography in the selection of liver transplantation candidates in patients with hepatocellular carcinoma. Hepatobiliary Pancreat Dis Int 16:257-263